Exscientia plc
NASDAQ: EXAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Hallett
- Employees
- 483
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2021
- Market cap
- $633.2M
- Website
- https://www.exscientia.ai
Loading EXAI…
Loading profile data…Frequently asked questions about EXAI
What does Exscientia plc (EXAI) do?
Exscientia plc is a pioneering pharmatech firm that leverages artificial intelligence (AI) to revolutionize drug discovery and development. The company provides a comprehensive, AI-driven platform that spans the entire drug development lifecycle. This integrated system supports crucial stages, including identifying disease targets, designing pot...
Where does EXAI trade?
Exscientia plc (EXAI) trades on the NASDAQ Global Select.
What sector is EXAI in?
Exscientia plc (EXAI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Exscientia plc?
David Hallett is the chief executive officer of Exscientia plc (EXAI).
Where is Exscientia plc headquartered?
Exscientia plc is headquartered in United Kingdom.
Does EXAI pay a dividend?
Exscientia plc (EXAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EXAI go public?
Exscientia plc (EXAI) completed its initial public offering in 2021.
Is EXAI an ADR?
Yes — EXAI is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Exscientia plc reporting and dividends follow the underlying issuer.